COVID-19 VACCINE PLANT TO OPEN IN SOUTH KOREA

Highlights: 

• SK bioscience of South Korea has received European Union Good Manufacturing Practices (GMP) certification. 
• The certification will approve the production and processing line and quality check system of the COVID-19 vaccines.
• SK biosciences have a license agreement with Novavax to produce 40 million COVID-19 vaccines for South Korea.

SK biosciences....